Galera Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

Galera Therapeutics

15/05/2023 13:32

* Galera Therapeutics Inc  GRTX.OQ  reported a quarterly
adjusted
loss of 50 cents​​ per share for the quarter ended in March. The
mean expectation of four analysts for the quarter was for a loss
of 38 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Galera Therapeutics Inc's reported EPS for the quarter was
a
loss of 50 cents​.
    * The mean earnings estimate of analysts had risen by
about 7.3%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Galera Therapeutics Inc shares had risen by 22.3% this
quarter and gained 110.1% so far this year.
    * The company reported a quarterly loss of $17.71 million.
    * Wall Street's median 12-month price target for Galera
Therapeutics Inc is $6.50 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
15 at 12:32 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.38          -0.50          Missed
 Dec. 31 2022      -0.54          -0.58          Missed
 Sep. 30 2022      -0.52          -0.60          Missed
 Jun. 30 2022      -0.53          -0.54          Missed